Hadasit

Hadasit is the venture-building and innovation company of Hadassah Medical Center in Jerusalem, with a thesis focused on biotech, medical devices, and digital health, and a track record of pushing medical ideas through their lifecycle from research to commercial deployment. Hadassah’s clinical and research depth is the structural advantage, particularly in fields where the hospital has unusual specialty strength.

The thesis is rooted in the Hadassah clinical and research environment. Hadasit identifies inventions and clinical insights within the hospital, supports the formation of companies around them, and provides early capital and structural support through the spinout process. Biotech, medical devices, and digital health are the most active categories, with AI in healthcare appearing where the underlying clinical insight is strong. The fund also engages with digital health accelerator programs, broadening the engagement model beyond pure spinouts.

Check sizes sit in the 250 thousand to 1 million dollar range, consistent with an early-stage and seed positioning. Stage focus runs from pre-seed through Series A, an unusually wide aperture for a hospital-affiliated investor, which means Hadasit can stay engaged with portfolio companies through more of the early-stage journey than a pure technology-transfer office. Geography is Israel-anchored, with the expectation that companies will engage United States and European commercial markets as they grow.

The team is built around clinicians, researchers, and commercialization operators embedded inside Hadassah, with deep institutional knowledge of the hospital’s clinical specialties and intellectual-property base. Diligence is built around the clinical context and the strength of the underlying invention.

Approach Hadasit when you are a Hadassah researcher, clinician, or graduate with a research-derived invention or clinical insight, or when you are an outside founder building a digital health company that would benefit from a Hadassah accelerator engagement. The most direct path in is through Hadassah clinicians, the hospital’s innovation programs, or the Hadasit office directly. Time the conversation when you have a research insight or early product idea, ideally with a clinical co-founder or sponsor inside the hospital. Founders should plan for a structured commercialization process and a long-term partnership with the medical center. Hadasit is particularly useful for founders whose products genuinely need Hadassah’s clinical specialty depth as a development partner rather than as a generic clinical site.